Ionis Pharmaceuticals CEO Stanley Crooke's 2019 pay jumps 26% to $9.6M
Ionis Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 24, 2020
Ionis Pharmaceuticals reported fiscal year 2019 executive compensation information on April 24, 2020.
In 2019, five executives at Ionis Pharmaceuticals received on average a compensation package of $5.4M, a 24% increase compared to previous year.
Average pay of disclosed executives at Ionis Pharmaceuticals
Stanley T. Crooke, Chief Executive Officer, received $9.6M in total, which increased by 26% compared to 2018. 41% of Crooke's compensation, or $3.9M, was in option awards. Crooke also received $926K in bonus, $912K in salary, $3.7M in stock awards, as well as $138K in other compensation.
For fiscal year 2019, the median employee pay was $270,956 at Ionis Pharmaceuticals. Therefore, the ratio of Stanley T. Crooke's pay to the median employee pay was 35 to one.
Brett Monia, Chief Operating Officer, received a compensation package of $6.5M, which increased by 53% compared to previous year. 43% of the compensation package, or $2.8M, was in option awards.
Richard S. Geary, Senior Vice President, Development, earned $3.9M in 2019, a 32% increase compared to previous year.
Elizabeth L. Hougen, Chief Financial Officer, received $3.5M in 2019, which increases by 25% compared to 2018.
Patrick R. O'Neil, General Counsel, earned $3.5M in 2019, a 24% increase compared to previous year.
Related executives
Stanley Crooke
Ionis Pharmaceuticals
Chairman
Elizabeth Hougen
Ionis Pharmaceuticals
Chief Financial Officer
Brett Monia
Ionis Pharmaceuticals
Chief Executive Officer
Richard Geary
Ionis Pharmaceuticals
Executive Vice President, Chief Development Officer
Patrick O'Neil
Ionis Pharmaceuticals
General Counsel
You may also like
Source: SEC filing on April 24, 2020.